UBS Group’s KraneShares MSCI All China Health Care Index ETF KURE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $809K | Sell |
51,389
-7,478
| -13% | -$123K | ﹤0.01% | 5907 |
|
|
2026
Q1 | $1M | Sell |
58,867
-43,352
| -42% | -$768K | ﹤0.01% | 5555 |
|
|
2025
Q4 | $1.74M | Buy |
102,219
+85,487
| +511% | +$1.63M | ﹤0.01% | 5094 |
|
|
2025
Q3 | $350K | Buy |
16,732
+11,705
| +233% | +$230K | ﹤0.01% | 6337 |
|
|
2025
Q2 | $85.1K | Sell |
5,027
-1,685
| -25% | -$26.8K | ﹤0.01% | 7365 |
|
|
2025
Q1 | $105K | Buy |
6,712
+5,859
| +687% | +$85.8K | ﹤0.01% | 7019 |
|
|
2024
Q4 | $12.1K | Sell |
853
-947
| -53% | -$14.7K | ﹤0.01% | 8215 |
|
|
2024
Q3 | $30.1K | Sell |
1,800
-1,226
| -41% | -$16.7K | ﹤0.01% | 7128 |
|
|
2024
Q2 | $40K | Buy |
3,026
+1,133
| +60% | +$16.3K | ﹤0.01% | 6863 |
|
|
2024
Q1 | $27.5K | Buy |
1,893
+114
| +6% | +$1.76K | ﹤0.01% | 6771 |
|
|
2023
Q4 | $31.1K | Buy |
1,779
+238
| +15% | +$4.25K | ﹤0.01% | 6823 |
|
|
2023
Q3 | $27.4K | Sell |
1,541
-100
| -6% | -$1.78K | ﹤0.01% | 6635 |
|
|
2023
Q2 | $29.6K | Buy |
+1,641
| New | +$32.7K | ﹤0.01% | 6724 |
|
|
2023
Q1 | – | Sell |
-1,789
| Closed | -$38.3K | – | 10001 |
|
|
2022
Q4 | $38.3K | Sell |
1,789
-5,717
| -76% | -$112K | ﹤0.01% | 7012 |
|
|
2022
Q3 | $133K | Buy |
7,506
+2,500
| +50% | +$52.1K | ﹤0.01% | 5459 |
|
|
2022
Q2 | $117K | Buy |
5,006
+443
| +10% | +$9.32K | ﹤0.01% | 5303 |
|
|
2022
Q1 | $106K | Sell |
4,563
-106,195
| -96% | -$2.61M | ﹤0.01% | 5874 |
|
|
2021
Q4 | $3.18M | Sell |
110,758
-3,159
| -3% | -$109K | ﹤0.01% | 3301 |
|
|
2021
Q3 | $4.26M | Buy |
113,917
+26,936
| +31% | +$1.05M | ﹤0.01% | 2841 |
|
|
2021
Q2 | $3.96M | Buy |
86,981
+13,794
| +19% | +$587K | ﹤0.01% | 2923 |
|
|
2021
Q1 | $2.85M | Buy |
73,187
+14,011
| +24% | +$573K | ﹤0.01% | 3200 |
|
|
2020
Q4 | $2.31M | Sell |
59,176
-8,231
| -12% | -$291K | ﹤0.01% | 3281 |
|
|
2020
Q3 | $2.26M | Buy |
67,407
+3,372
| +5% | +$115K | ﹤0.01% | 2935 |
|
|
2020
Q2 | $2.04M | Sell |
64,035
-63,140
| -50% | -$1.73M | ﹤0.01% | 2861 |
|
|
2020
Q1 | $3.02M | Buy |
127,175
+123,266
| +3,153% | +$3M | ﹤0.01% | 2372 |
|
|
2019
Q4 | $91K | Sell |
3,909
-2,643
| -40% | -$60.1K | ﹤0.01% | 6050 |
|
|
2019
Q3 | $138K | Buy |
6,552
+4,557
| +228% | +$95.2K | ﹤0.01% | 5547 |
|
|
2019
Q2 | $41K | Buy |
1,995
+815
| +69% | +$17.1K | ﹤0.01% | 6087 |
|
|
2019
Q1 | $26K | Sell |
1,180
-1,649
| -58% | -$32.7K | ﹤0.01% | 6064 |
|
|
2018
Q4 | $48K | Buy |
2,829
+1,452
| +105% | +$29K | ﹤0.01% | 6120 |
|
|
2018
Q3 | $31K | Buy |
1,377
+371
| +37% | +$8.96K | ﹤0.01% | 6508 |
|
|
2018
Q2 | $27K | Buy |
+1,006
| New | +$28.3K | ﹤0.01% | 6473 |
|
Other funds holding KURE
SP
FP
UBS Group's KURE Position: Q2 2026 in Review
UBS Group reduced its KraneShares MSCI All China Health Care Index ETF (KURE) stake by 13% in Q2 2026, selling an estimated $123K and leaving 51,389 shares worth $809K. The position accounts for ﹤0.01% of the portfolio, ranked #5907.
UBS Group first reported a position in KURE in Q2 2018 and has held it in 32 quarters since. The position peaked at $4.26M in Q3 2021. 13 funds tracked by Wall St. Rank hold KURE as of Q2 2026.
- UBS Group held 51,389 shares of KraneShares MSCI All China Health Care Index ETF worth $809K as of Q2 2026.
- UBS Group sold 7,478 KraneShares MSCI All China Health Care Index ETF shares in Q2 2026, an estimated $123K.
- KraneShares MSCI All China Health Care Index ETF made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #5907 holding.
- UBS Group first reported a position in KraneShares MSCI All China Health Care Index ETF in Q2 2018 and has held it in 32 quarters since.
- UBS Group's KraneShares MSCI All China Health Care Index ETF position peaked at $4.26M in Q3 2021.
- 13 funds tracked by Wall St. Rank held KraneShares MSCI All China Health Care Index ETF as of Q2 2026.
Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.